Meet our SPARK Fellows

Introducing Cohort 8

Achim Klug Image

Achim Klug, PhD

Hearing Restoration for Age-Related Hearing Loss

Hearing Restoration for Age-Related Hearing Loss

Our technology addresses age-related central hearing loss, a condition affecting the auditory brain and making it difficult for individuals to follow conversations in noisy environments. We propose a treatment combining a long-approved FDA drug with an engineered sound file to restore auditory brain circuits. This one-month therapy aims to benefit over 100 million people in North America, Europe, and Japan. We will demonstrate the treatment's efficacy, explore regulatory pathways, and prepare for commercialization with NIH and SPARK funding. The project includes clinical trials and customer discovery, aiming for successful licensing or the startup of a new company. 

Learn more about Dr. Klug

Cohort 7

Jessica Rove, MD

Jessica Rove, MD

Colorado Chest Tube

Juan-Pablo Idrovo, MD

Juan-Pablo Idrovo, MD

Gastrostomy Tube Guardian

Rui Zhao, PhD

Rui Zhao, PhD

Developing a First-in-Class Allosteric Eya2 Tyrosine Phosphatase Inhibitor for Brain Cancer Therapy

Sujatha Venkataraman, PhD

Development of Gated Dual-antigen Targeting CAR-T Cell Therapy to Treat ATRT, an Aggressive Brain Tumor in Children

zhirui_wang_500

Zhirui Wang, PhD

Bivalent CD47 Immunotoxin for Targeted Therapy of T-Cell Acute Lymphoblastic Leukemia and Other CD47+ Cancers

Cohort 6

Achim Klug Image

Achim Klug, PhD

Hearing Restoration for Age-Related Hearing Loss

Hearing Restoration for Age-Related Hearing Loss

Our technology addresses age-related central hearing loss, a condition affecting the auditory brain and making it difficult for individuals to follow conversations in noisy environments. We propose a treatment combining a long-approved FDA drug with an engineered sound file to restore auditory brain circuits. This one-month therapy aims to benefit over 100 million people in North America, Europe, and Japan. We will demonstrate the treatment's efficacy, explore regulatory pathways, and prepare for commercialization with NIH and SPARK funding. The project includes clinical trials and customer discovery, aiming for successful licensing or the startup of a new company. 

Learn more about Dr. Klug

Cohort 5

Achim Klug Image

Achim Klug, PhD

Hearing Restoration for Age-Related Hearing Loss

Hearing Restoration for Age-Related Hearing Loss

Our technology addresses age-related central hearing loss, a condition affecting the auditory brain and making it difficult for individuals to follow conversations in noisy environments. We propose a treatment combining a long-approved FDA drug with an engineered sound file to restore auditory brain circuits. This one-month therapy aims to benefit over 100 million people in North America, Europe, and Japan. We will demonstrate the treatment's efficacy, explore regulatory pathways, and prepare for commercialization with NIH and SPARK funding. The project includes clinical trials and customer discovery, aiming for successful licensing or the startup of a new company. 

Learn more about Dr. Klug

Cohort 4

Cohort 3

Cohort 2

Cohort 1

CU Innovations

CU Anschutz

Anschutz Health Sciences Building

1890 N Revere Ct

Suite 6202

Mail Stop F411

Aurora, CO 80045


303-724-3720

CMS Login